Dup15q Syndrome is a neurogenetic disorder, which results from duplications of chromosome 15q11.2-13.1. It is characterized by hypotonia, developmental delay, intellectual disability (ID), epilepsy, and autism spectrum disorder (ASD).
&nbsp;
Based on the mechanism of action of duplication, Dup15q syndrome is categorized into two types, i.e., isodicentric 15 chromosomes [idic(15)] and interstitial duplication 15 [int dup(15)]. Idic(15) is found in most cases, wherein the individuals with Idic (15) have an extra chromosome formed due to a duplicated and inverted portion of chromosome 15. Besides, in int dup(15), a section of the q arm of chromosome 15 gets duplicated.
&nbsp;
<a href="https://www.delveinsight.com/report-store/dup15q-syndrome-epidemiology-forecast">Dup15q Syndrome Epidemiological Segmentation</a>
The Epidemiological Segmentation of Dup15q Syndrome in 7MM from 2017 to 2030 is segmented as:-&nbsp;
<ul>
<li>Total Prevalent Cases of Dup15q Syndrome</li>
<li>Total Diagnosed Prevalence of Dup15q Syndrome</li>
<li>Type-specific Diagnosed Prevalence of Dup15q Syndrome</li>
</ul>
&nbsp;
Dup15q Syndrome Epidemiology&nbsp;
<ul>
<li>The total prevalent population of Dup15q syndrome in 7MM in 2017 was 45,884&nbsp;&nbsp;</li>
<li>The prevalence of Dup15q syndrome in the United States in 2017 was 22,077&nbsp;&nbsp;</li>
<li>The total diagnosed prevalent cases of Dup15q syndrome in the US in 2017 was 4,415&nbsp;&nbsp;</li>
</ul>
&nbsp;
<a style="color: #0066cc; background-color: transparent;" href="https://www.delveinsight.com/report-store/dup15q-syndrome-market-forecast" target="_blank" rel="noopener noreferrer">Dup15q Syndrome Market</a>
The market size of Dup15q syndrome in 7MM in 2017 was USD 15.69 Million
&nbsp;
Dup15q Syndrome Market Drivers
<ul>
<li>Identification of electroencephalogram (EEG) biomarker</li>
<li>Support and awareness from disease advocacy groups</li>
<li>Expected launch of Soticlestat (OV935/TAK935)</li>
</ul>
&nbsp;
Dup15q Syndrome Market Barriers
<ul>
<li>Limited understanding of the genes and biomarkers</li>
<li>Low awareness about the disease</li>
<li>Limited epidemiological information</li>
<li>Unavailability of treatment and diagnostic guidelines</li>
<li>No approved therapy and weak emerging pipeline</li>
</ul>
&nbsp;
Dup15q Syndrome Emerging Drugs
The emerging drugs of the Dup15q Syndrome market are&nbsp;
<ul>
<li>Soticlestat (OV935/TAK-935)</li>
</ul>
And many others.&nbsp;&nbsp;
&nbsp;
Dup15q Syndrome Key Players
The key players in the Dup15q Syndrome market are
<ul>
<li>Ovid Therapeutics</li>
<li>Takeda&nbsp;</li>
</ul>
And many others.&nbsp;

Dup15q Syndrome Market

Dup15q Syndrome Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.